Correlation Between ZyVersa Therapeutics and Novavax
Can any of the company-specific risk be diversified away by investing in both ZyVersa Therapeutics and Novavax at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ZyVersa Therapeutics and Novavax into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ZyVersa Therapeutics and Novavax, you can compare the effects of market volatilities on ZyVersa Therapeutics and Novavax and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ZyVersa Therapeutics with a short position of Novavax. Check out your portfolio center. Please also check ongoing floating volatility patterns of ZyVersa Therapeutics and Novavax.
Diversification Opportunities for ZyVersa Therapeutics and Novavax
0.74 | Correlation Coefficient |
Poor diversification
The 3 months correlation between ZyVersa and Novavax is 0.74. Overlapping area represents the amount of risk that can be diversified away by holding ZyVersa Therapeutics and Novavax in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Novavax and ZyVersa Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ZyVersa Therapeutics are associated (or correlated) with Novavax. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Novavax has no effect on the direction of ZyVersa Therapeutics i.e., ZyVersa Therapeutics and Novavax go up and down completely randomly.
Pair Corralation between ZyVersa Therapeutics and Novavax
Given the investment horizon of 90 days ZyVersa Therapeutics is expected to under-perform the Novavax. In addition to that, ZyVersa Therapeutics is 3.25 times more volatile than Novavax. It trades about -0.15 of its total potential returns per unit of risk. Novavax is currently generating about -0.14 per unit of volatility. If you would invest 974.00 in Novavax on August 26, 2024 and sell it today you would lose (127.00) from holding Novavax or give up 13.04% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
ZyVersa Therapeutics vs. Novavax
Performance |
Timeline |
ZyVersa Therapeutics |
Novavax |
ZyVersa Therapeutics and Novavax Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with ZyVersa Therapeutics and Novavax
The main advantage of trading using opposite ZyVersa Therapeutics and Novavax positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ZyVersa Therapeutics position performs unexpectedly, Novavax can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Novavax will offset losses from the drop in Novavax's long position.ZyVersa Therapeutics vs. Cns Pharmaceuticals | ZyVersa Therapeutics vs. Immix Biopharma | ZyVersa Therapeutics vs. Hepion Pharmaceuticals | ZyVersa Therapeutics vs. Zura Bio Limited |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Complementary Tools
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
CEOs Directory Screen CEOs from public companies around the world | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |